Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bendik Lund

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Cancer Chemotherapy and Pharmacology|April 30, 2021
No association between relapse hazard and thiopurine methyltransferase geno- or phenotypes in non-high risk acute lymphoblastic leukemia: a NOPHO ALL2008 sub-studyStine Nygaard Nielsen, Linea Natalie Toksvang, Kathrine Grell, et al.
Blood|November 5, 2020
Relapse risk following truncation of pegylated asparaginase in childhood acute lymphoblastic leukemiaSofie Gottschalk Højfeldt, Kathrine Grell, Jonas Abrahamsson, et al.
British Journal of Haematology|November 20, 2018
Genetic predisposition to PEG-asparaginase hypersensitivity in children treated according to NOPHO ALL2008Sofie G Højfeldt, Benjamin O Wolthers, Morten Tulstrup, et al.
British Journal of Haematology|January 26, 2019
Low burden of minimal residual disease prior to transplantation in children with very high risk acute lymphoblastic leukaemia: The NOPHO ALL2008 experienceMarianne Ifversen, Dominik Turkiewicz, Hanne V Marquart, et al.
Pediatric Blood & Cancer|March 22, 2022
Characteristics of white blood cell count in acute lymphoblastic leukemia: A COST LEGEND phenotype-genotype studyMarianne Helenius, Goda Vaitkeviciene, Jonas Abrahamsson, et al.
Blood|June 19, 2010
Spectrum of clinical presentations in familial hemophagocytic lymphohistiocytosis type 5 patients with mutations in STXBP2Marie Meeths, Miriam Entesarian, Waleed Al-Herz, et al.
Haematologica|February 20, 2025
Impact of age and sex on survival outcomes in patients aged 1-45 years with acute lymphoblastic leukemia treated according to the stratification used in the NOPHO ALL2008 trialTuomas Lahteenmaki Taalas, Trausti Oskarsson, Mats Heyman, et al.
Blood|May 12, 2020
Effects of germline DHFR and FPGS variants on methotrexate metabolism and relapse of leukemiaMorten Tulstrup, Takaya Moriyama, Chuang Jiang, et al.
Leukemia|September 12, 2018
NT5C2 germline variants alter thiopurine metabolism and are associated with acquired NT5C2 relapse mutations in childhood acute lymphoblastic leukaemiaMorten Tulstrup, Marie Grosjean, Stine Nygaard Nielsen, et al.
Leukemia|June 27, 2021
DNA-thioguanine concentration and relapse risk in children and young adults with acute lymphoblastic leukemia: an IPD meta-analysisLinea N Toksvang, Kathrine Grell, Jacob Nersting, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Cancer Chemotherapy and Pharmacology|April 30, 2021
No association between relapse hazard and thiopurine methyltransferase geno- or phenotypes in non-high risk acute lymphoblastic leukemia: a NOPHO ALL2008 sub-studyStine Nygaard Nielsen, Linea Natalie Toksvang, Kathrine Grell, et al.
Blood|November 5, 2020
Relapse risk following truncation of pegylated asparaginase in childhood acute lymphoblastic leukemiaSofie Gottschalk Højfeldt, Kathrine Grell, Jonas Abrahamsson, et al.
British Journal of Haematology|November 20, 2018
Genetic predisposition to PEG-asparaginase hypersensitivity in children treated according to NOPHO ALL2008Sofie G Højfeldt, Benjamin O Wolthers, Morten Tulstrup, et al.
British Journal of Haematology|January 26, 2019
Low burden of minimal residual disease prior to transplantation in children with very high risk acute lymphoblastic leukaemia: The NOPHO ALL2008 experienceMarianne Ifversen, Dominik Turkiewicz, Hanne V Marquart, et al.
Pediatric Blood & Cancer|March 22, 2022
Characteristics of white blood cell count in acute lymphoblastic leukemia: A COST LEGEND phenotype-genotype studyMarianne Helenius, Goda Vaitkeviciene, Jonas Abrahamsson, et al.
Blood|June 19, 2010
Spectrum of clinical presentations in familial hemophagocytic lymphohistiocytosis type 5 patients with mutations in STXBP2Marie Meeths, Miriam Entesarian, Waleed Al-Herz, et al.
Haematologica|February 20, 2025
Impact of age and sex on survival outcomes in patients aged 1-45 years with acute lymphoblastic leukemia treated according to the stratification used in the NOPHO ALL2008 trialTuomas Lahteenmaki Taalas, Trausti Oskarsson, Mats Heyman, et al.
Blood|May 12, 2020
Effects of germline DHFR and FPGS variants on methotrexate metabolism and relapse of leukemiaMorten Tulstrup, Takaya Moriyama, Chuang Jiang, et al.
Leukemia|September 12, 2018
NT5C2 germline variants alter thiopurine metabolism and are associated with acquired NT5C2 relapse mutations in childhood acute lymphoblastic leukaemiaMorten Tulstrup, Marie Grosjean, Stine Nygaard Nielsen, et al.
Leukemia|June 27, 2021
DNA-thioguanine concentration and relapse risk in children and young adults with acute lymphoblastic leukemia: an IPD meta-analysisLinea N Toksvang, Kathrine Grell, Jacob Nersting, et al.
Pageof 4